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The in vitro antibacterial and antibiofilm activity of chlorogenic acid against clinical isolates 
of Stenotrophomonas maltophilia was investigated through disk diffusion, minimum 
inhibitory concentration (MIC), minimum bactericidal concentration (MBC), time-kill and 
biofilm assays. A total of 9 clinical S. maltophilia isolates including one isolate resistant to 
trimethoprim / sulfamethoxazole (TMP/SMX) were tested. The inhibition zone sizes for the 
isolates ranged from 17 to 29 mm, while the MIC and MBC values ranged from 8 to 16 g 
mL-1 and 16 to 32 g mL-1. Chlorogenic acid appeared to be strongly bactericidal at 4x MIC, 
with a 2-log reduction in viable bacteria at 10 h. In vitro antibiofilm testing showed a 4-fold 
reduction in biofilm viability at 4x MIC compared to 1x MIC values (0.085 < 0.397 A 490 
nm) of chlorogenic acid. The data from this study support the notion that the chlorogenic acid 
has promising in vitro antibacterial and antibiofilm activities against S. maltophilia. 
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